Highest-materiality recent filing
Shareholders approve 2026 Incentive Plan authorizing 12M shares; directors elected
Annual meeting held July 16, 2026; quorum of 58.46% of outstanding shares represented.
Radnostix acquires Lara System assets for $900K; issues $500K convertible note to related party
Acquired Lara System and Ellexa Explorer assets from Lucerno Dynamics for $150K cash + $750K in stock (20-day VWAP).
Radnostix extends Series C Preferred maturity to February 28, 2028
Majority of Series C Preferred holders approved extension of maturity date by one year to February 28, 2028.
Radnostix terminates $12.45M DUF6 plant sale to AFR; voluntary capsule recall
APA terminated mutually on March 11, 2026; AFR could not pay $12.45M balance by March 31, 2026.
International Isotopes changes name to Radnostix; ticker INIS unchanged
Name changed from International Isotopes Inc. to Radnostix, Inc. effective December 23, 2025.
International Isotopes CEO Bagerdjian signs 5-year employment agreement; Dr. Fu appointed to board
CEO Shahe Bagerdjian's base salary set at $314K with automatic 5% annual increases through 2030 and up to $250K in milestone raises based on quarterly revenue hitting $3.75M–$25M.
CEO Shahe Bagerdjian signs new employment agreement with $314,000 base salary, 5% annual increases, and 37,500,000 RSUs vesting at share price milestones up to $0.30.
International Isotopes shareholders approve reverse stock split, re-elect directors
Shareholders approved amendment to certificate of formation for reverse stock split at ratio 1:50 to 1:275, with exact ratio set by Board.
International Isotopes extends Series C Preferred maturity to Feb 28, 2027
Majority of Series C Preferred stockholders approved a two-year maturity extension to February 28, 2027.
International Isotopes elects four directors, ratifies auditor at 2024 annual meeting
Shareholders elected Robert Atcher, Shahe Bagerdjian, Christopher Grosso, and Steve T. Laflin as directors for one-year terms.
International Isotopes sells depleted uranium deconversion assets to AFR for $12.5M
Sale of DUF 6 plant assets to American Fuel Resources for $12.5M cash at closing, plus $50K prepayment.
CEO Steve Laflin to step down Sept 1; President Shahe Bagderjian named successor and joins board
Steve Laflin resigns as CEO effective Sept 1, 2023 after 22 years; remains on board as director and consultant.
International Isotopes appoints Shahe Bagerdjian as President effective May 8, 2023
Shahe Bagerdjian, former GMS SVP Operations & Business Development, named President.
International Isotopes extends CEO Steve Laflin's term to Aug 2023, provides $25K transition bonus
Amendment extends CEO Steve Laflin's employment agreement to August 31, 2023.
International Isotopes extends Series C Preferred maturity to Feb 28, 2025
Majority of Series C Preferred stockholders approved a two-year maturity extension.
Shareholders approve reverse stock split 1-for-20 to 1-for-150 at annual meeting
Steve T. Laflin, Christopher Grosso, Robert Atcher re-elected as directors; each received >212M votes for.
International Isotopes completes $4M asset sale to Pharmalogic; extends Series C Preferred maturity
Completed sale of manufacturing equipment and sublease to Pharmalogic Idaho for $4.0M cash on Feb 18, 2022.
International Isotopes to sell manufacturing equipment and sublease to Pharmalogic for $4.0M cash
Asset Purchase Agreement signed Feb 10, 2022; Pharmalogic Idaho, LLC to pay $4.0 million cash.
Acquired remaining 75% of RadQual for $4.4M, paying 40,176,236 shares at $0.11/share based on 60-day VWAP.
In addition, on July 12, 2023, Shahe Bagderjian, President of the Company, was appointed to replace Mr. Laflin as Chief Executive Officer, effective September 1, 2023.
On July 12, 2023, Steve T. Laflin gave notice that he is stepping down as Chief Executive Officer of the Company, effective as of September 1, 2023 at the end of the term of his employment agreement.
On July 12, 2023, the Board, pursuant to the Restated Certificate of Formation of the Company and the Bylaws of the Company, approved an increase of the size of the Board from three directors to four directors, and appointed Shahe Bagderjian to serve as a director on the Board, effectively immediately.
On May 8, 2023, International Isotopes Inc. (the “Company”) appointed Shahe Bagerdjian as its President, effective immediately.
Max materiality 0.80 · Median 0.60 · Most common event other_material